7215-01-2 Usage
Description
3-(4-bromophenyl)azetidine is a 3-phenylazetidine derivative, which is a type of organic compound with a specific molecular structure. It has been studied for its pharmacological properties and has demonstrated slight sympathomimetic effects in animals.
Uses
Used in Pharmaceutical Industry:
3-(4-bromophenyl)azetidine is used as a pharmaceutical compound for its sympathomimetic effects. 3-(4-bromophenyl)azetidine has shown potential in pharmacology studies, where it exhibited slight stimulation of the sympathetic nervous system in animals. This property could be harnessed for the development of medications targeting conditions related to the sympathetic nervous system.
Used in Research and Development:
3-(4-bromophenyl)azetidine is also used as a research compound in the field of medicinal chemistry and pharmacology. Its unique structure and observed effects make it a valuable tool for understanding the mechanisms of drug action and for the development of new therapeutic agents with improved efficacy and safety profiles.
Check Digit Verification of cas no
The CAS Registry Mumber 7215-01-2 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 7,2,1 and 5 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 7215-01:
(6*7)+(5*2)+(4*1)+(3*5)+(2*0)+(1*1)=72
72 % 10 = 2
So 7215-01-2 is a valid CAS Registry Number.
InChI:InChI=1/C9H10BrN/c10-9-3-1-7(2-4-9)8-5-11-6-8/h1-4,8,11H,5-6H2
7215-01-2Relevant articles and documents
6-SUBSTITUTED PYRIDAZINE COMPOUNDS AS SMARCA2 AND/OR SMARCA4 DEGRADERS
-
Page/Page column 70; 71, (2022/02/15)
The present invention provides 6-substituted pyridazine compounds of formula (I), which are therapeutically useful as SMARCA2 and/or SMARCA4 degraders. These compounds are useful in the treatment and/or delaying progression of diseases or disorders dependent upon SMARCA2 and/or SMARCA4 in a subject. The present invention also provides preparation of the compounds and pharmaceutical compositions comprising at least one of the compounds of formula (I) or a pharmaceutically acceptable salt, or a stereoisomer or a tautomer or a prodrug thereof.
